ArticleClinical kidney journal2022

Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response.

Noelle K X Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.